(Q34583454)

3 August 2017

title

Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily (English)

1 reference

3 August 2017

1 reference

3

Jonathan Corren

1 reference

3 August 2017

William Lumry

1

1 reference

3 August 2017

Bruce Prenner

series ordinal

2

1 reference

3 August 2017

William Wheeler

series ordinal

4

1 reference

3 August 2017

publication date

1 September 2007

1 reference

Annals of Allergy, Asthma & Immunology

3 August 2017

published in

1 reference

3 August 2017

volume

99

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

267-272

1 reference

A comparison of azelastine nasal spray and cetirizine tablets in the treatment of allergic rhinitis

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960663-1

7 January 2021

A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960663-1

7 January 2021

Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960663-1

7 January 2021

A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960663-1

7 January 2021

A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960663-1

7 January 2021

Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis: a 4-week comparative multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960663-1

7 January 2021

Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960663-1

7 January 2021

Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960663-1

7 January 2021

Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960663-1

7 January 2021

Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960663-1

7 January 2021

Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960663-1

7 January 2021

10.1016/S1081-1206(10)60663-1

Identifiers

DOI

1 reference

release_7nvvjorof5cw5knad2tnivcy6i

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7nvvjorof5cw5knad2tnivcy6i

24 November 2022

mapped directly with Wikidata item

1 reference